Atorvastatin Calcium
Product Images NDC 68071-2872

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2872 3)

Atorvastatin Calcium 40mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets, with a prescription-only designation. The tablets are film-coated, contain Atorvastatin Calcium Trihydrate equivalent to 40mg Atorvastatin, and are elliptical white debossed with 'RX 829' on one side. Storage instructions specify controlled temperature between 68-77°F.*

FDA Label Image

Structure (Image 01)

Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ions, consistent with the known composition of the active ingredient Atorvastatin Calcium.*

FDA Label Image

Figure1 (Image 02)

A Kaplan-Meier cumulative incidence curve comparing Atorvastatin and Placebo over approximately 3.5 years. The y-axis represents cumulative incidence percentage, and the x-axis represents years. Atorvastatin shows a lower cumulative incidence than Placebo. The graph includes a hazard ratio (HR=0.64) and a p-value (0.0005).*

FDA Label Image

Figure 2 (Image 03)

A Kaplan-Meier plot showing cumulative hazard percentage over time comparing Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint in years through four years of follow-up, while the y-axis depicts cumulative hazard percentage. The graph includes hazard ratio (HR) 0.63 with confidence interval and p-value 0.001.*

FDA Label Image

Figure 3 (Image 04)

A line chart depicting the percentage of subjects experiencing an event over time in years up to 5 years for Atorvastatin 10 mg and 80 mg. The chart compares the time to the first major cardiovascular endpoint for both dosages, with a hazard ratio (HR) of 0.78 (0.69-0.89) and a p-value of 0.0002 shown on the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.